Finance
Bayer to exit US seed treatment equipment business, email says
Published by Global Banking & Finance Review®
Posted on May 1, 2025
2 min readLast updated: January 24, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on May 1, 2025
2 min readLast updated: January 24, 2026
Bayer exits US seed treatment equipment business to focus on crop protection, aiming to improve financial stability amid legal challenges.
By Tom Polansek
CHICAGO (Reuters) - Bayer is exiting the seed treatment equipment business in the United States to help the company's finances, according to an email sent to customers that was seen by Reuters on Wednesday.
The German maker of drugs and farming pesticides has struggled recently with weak earnings, rising legal costs and a lagging share price.
A spokesperson confirmed that Bayer was exiting the business, which manufactured equipment involved in the process of treating farm seeds with products like fungicides and insecticides before planting in efforts to protect crop yields.
"This is a difficult decision, but necessary to help secure the financial future of the company," the email said. It added that Bayer decided to direct resources toward primary areas of strength in crop protection products.
The company will begin the process of closing a seed treatment equipment manufacturing facility in Shakopee, Minnesota, over the next few months, according to the email.
Bayer in 2015 opened a $12 million SeedGrowth Equipment Innovation Center in Shakopee that sought to improve research links between equipment and seed treatment products.
Bayer is committed to seed treatments though it will no longer manufacture seed treatment equipment, the email said.
CEO Bill Anderson has faced investor pressure to deliver on restructuring efforts and reverse what is projected to be the third consecutive annual drop in operating income in 2025.
The company is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide glyphosate but is also prepared for a possible exit from that market, Anderson said this month.
(Reporting by Tom Polansek; Editing by Aurora Ellis)
Bayer's exit from the US seed treatment equipment business to focus on crop protection and improve financial stability.
To secure financial future and focus on primary strengths in crop protection products.
Weak earnings, rising legal costs, and pressure to reverse income decline.
Explore more articles in the Finance category
